Eisai Completes Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan
To Strengthen its Research and Development Function for Injectable Drug FormulationsTOKYO, Oct 4, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced that, as part of the strategic investment towards the
Eisai Co Ltd Public Relations Department Eisai Medicine Innovation Technology Solutions Development Function For Injectable Drug Formulations Development Function Injectable Drug
Source: finanznachrichten.de